The progress made in liver disease research to date presents an opportunity for further advancements in the near future.

That’s it for 2025’s Q1 clinical trials round-up. If you have a study that could fit the bill for our next column, please ...

In the REAL8 basket trial, Sogroya (somapacitan), administered as a once-weekly subcutaneous injection, was at least as ...

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

Just a few months after announcing a plan to separate its drug and cell therapy businesses into two separate companies, ...

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

Netherlands biotech Azafaros is poised to start phase 3 trials of its lead drug for a trio of rare lysosomal storage ...

Improving Global Access to Life-Changing Therapeutics... Following the successful Boston and London meetings, the ...

A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

"We can use…AI to estimate a person's biological age from face pictures, and our study shows that information can be ...